We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and ferti... Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue. Show more
Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule PR Newswire JIUQUAN, China, Jan. 12, 2024 JIUQUAN, China, Jan. 12, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1097 | 16.1323529412 | 0.68 | 0.964 | 0.6421 | 34945 | 0.84298477 | CS |
4 | 0.1697 | 27.3709677419 | 0.62 | 0.964 | 0.5501 | 450189 | 0.71265626 | CS |
12 | 0.1977 | 33.3952702703 | 0.592 | 0.964 | 0.3551 | 174000 | 0.6916738 | CS |
26 | 0.2097 | 36.1551724138 | 0.58 | 0.964 | 0.3551 | 91354 | 0.68217799 | CS |
52 | -0.3803 | -32.5042735043 | 1.17 | 1.2974 | 0.3551 | 46931 | 0.6868725 | CS |
156 | -3.5603 | -81.8459770115 | 4.35 | 4.99 | 0.3551 | 28390 | 1.845722 | CS |
260 | -7.2203 | -90.1410736579 | 8.01 | 22 | 0.3551 | 74621 | 6.41593116 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions